Health & Fitness
Promising Coronavirus Vaccine Trial To Go Ahead At University of Chicago
The company that makes it, Moderna, announced late Tuesday that the mRNA-1273 vaccine has induced immune responses in all volunteers so far.
CHICAGO (CBS) — Promising results were announced Tuesday for a possible COVID-19 vaccine with ties to Chicago.
The company that makes it, Moderna, announced late Tuesday that the mRNA-1273 vaccine has induced immune responses in all volunteers in this Phase 1 study. The vaccine was given 28 days apart in three dose levels to 45 healthy participants between the ages of 18 and 55.
